10/10/2026
🚨 MA*****NA RESCHEDULING DELAYED AGAIN!
The DEA has temporarily paused the federal effort to move ma*****na from Schedule I to Schedule III, with a critical deadline approaching on October 13, 2026.
But here's what many headlines are missing: Rescheduling has NOT been rejected.
The latest delay involves a government watchdog report questioning federal drug scheduling procedures, not the scientific evidence supporting ma*****na's medical use.
With billions of dollars in potential tax relief and major implications for patients, researchers, and the cannabis industry hanging in the balance, all eyes are back on Washington.
Is this another unnecessary bureaucratic delay, or a legitimate step toward getting the process right?
📖 Read the full story at 420 Magazine:
https://www.420magazine.com/featured-articles/ma*****na-rescheduling-dea-delay-2026/
*****naRescheduling
Ma*****na rescheduling faces delay as the DEA pauses its Schedule III proceeding and the federal government faces an October 13 deadline.